2021-01-06,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of uniQure N.V. - QURE
2021-01-04,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V. - QURE
2020-12-29,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of uniQure N.V. - QURE
2020-12-26,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V. - QURE
2020-12-23,"QURE INVESTIGATION: Bronstein, Gewirtz & Grossman, LLC Announces uniQure N.V. Investigation"
2020-12-23,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V. - QURE
2020-12-21,Is QURE A Good Stock To Buy According To Hedge Funds?
2020-12-21,"Genetics Stocks Ablaze: Editas, Crispr, Intellia Rocket; Uniqure Dives"
2020-12-21,UniQure Hemophilia Therapy Placed on FDA Clinical Hold
2020-12-21,UniQure Plunges As FDA Slaps Clinical Hold On Hemophilia B Gene Therapy Study On Possible Liver Cancer Link
2020-12-21,uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program
2020-12-18,"The Zacks Analyst Blog Highlights: BioMarin Pharmaceutical, uniQure, REGENXBIO and Deciphera Pharmaceuticals"
2020-12-17,4 Biotechs That Could Be Potential Acquisition Targets in 2021
2020-12-15,This Gene Therapy Stock Is Ablaze On Eli Lilly's $1.04 Billion Takeover
2020-12-08,uniQure Presents Late-Breaking Data from the HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B at the 62nd Annual Meeting of the American Society of Hematology
2020-12-07,uniQure Announces Two-Year Follow-Up Data from the Phase IIb Study of Etranacogene Dezaparvovec and Long-Term Follow-Up Data for AMT-060 in Patients with Hemophilia B
2020-12-02,uniQure to Participate in Multiple Upcoming Industry Conferences in December
2020-11-30,uniQure Announces Multiple Presentations and Investor Webcast on Hemophilia B Gene Therapy Program at the 62nd American Society of Hematology (ASH) Annual Meeting
2020-11-19,Uniqure Hits Pay Dirt In Gene Therapy And The Biotech Stock Bounds Higher
2020-11-19,uniQure Announces Positive Top-Line Data from the HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B
2020-11-12,Brokers Are Upgrading Their Views On uniQure N.V. (NASDAQ:QURE) With These New Forecasts
2020-11-04,uniQure Announces Clinical Data Presentations at the  62nd American Society of Hematology (ASH) Annual Meeting
2020-11-04,uniQure to Participate in Multiple Upcoming Industry Conferences in November
2020-10-29,The Consensus EPS Estimates For uniQure N.V. (NASDAQ:QURE) Just Fell Dramatically
2020-10-27,"UniQure (QURE) Reports Q3 Loss, Lags Revenue Estimates"
2020-10-27,uniQure Announces Third Quarter 2020 Financial Results and Highlights Recent Company Progress
2020-10-26,5 Healthcare Stocks the Experts at Aquilo Capital Management Are Buying (1 Has Gained 88% This Month)
2020-10-26,Were Hedge Funds Right About Piling Into Uniqure NV (QURE)?
2020-10-19,UniQure (QURE) to Report Q3 Results: Wall Street Expects Earnings Growth
2020-10-13,uniQure Announces Enrollment of Next Two Patients in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntingtons Disease
2020-09-30,uniQure to Participate in Multiple Upcoming Industry Conferences in October
2020-09-25,uniQure Announces Recommendations from Data Safety Monitoring Board of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntingtons Disease
2020-09-23,3 Strong Buy Stocks That Are Flirting With a Bottom
2020-09-15,Loss-Making uniQure N.V. (NASDAQ:QURE) Set To Breakeven
2020-09-03,uniQure to Participate in Multiple Upcoming Industry Conferences in September
2020-08-31,Hedge Funds Cant Buy Enough Of Uniqure NV (QURE)
2020-08-31,Implied Volatility Surging for uniQure (QURE) Stock Options
2020-08-26,5 Biotech Stocks That Could Be Worth a Look
2020-08-26,"uniQure Announces Appointment of Ricardo Dolmetsch, Ph.D., as President, Research & Development"
2020-07-30,"UniQure (QURE) Reports Q2 Loss, Lags Revenue Estimates"
2020-07-30,uniQure Announces Second Quarter 2020 Financial Results and Highlights Recent Company Progress
2020-07-27,UniQure (QURE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
2020-07-08,Were Hedge Funds Right About Piling Into Uniqure NV (QURE)?
2020-06-25,"The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy"
2020-06-25,UniQure's shares fall on licensing deal for gene therapy
2020-06-24,CSL Behring Agrees to Acquire Novel Late-Stage Gene Therapy Candidate for Hemophilia B Patients from uniQure
2020-06-24,uniQure Announces License Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy
2020-06-19,uniQure Announces First Two Patients Treated in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntingtons Disease
2020-06-17,"uniQure Announces the Appointment of Leonard E. Post, Ph.D. to its Board of Directors"
2020-06-15,uniQure Announces Change for its 2020 Annual General Meeting of Shareholders
2020-06-01,Moving Average Crossover Alert: uniQure
2020-05-29,Hedge Funds Done Buying Uniqure NV (QURE)?
2020-05-18,Analysts Have Just Cut Their uniQure N.V. (NASDAQ:QURE) Revenue Estimates By 16%
2020-05-14,"uniQure Presents New Preclinical Data in SCA3, Fabry Disease, and Hemophilia A at the ASGCT Annual Meeting"
2020-05-11,JPMorgan Genetic-Therapies Fund Finds Success in Covid-19 Era
2020-04-29,"UniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates"
2020-04-29,uniQure Announces First Quarter 2020 Financial Results and Highlights Recent Company Progress
2020-04-28,uniQure Announces Significant Presence at Upcoming American Society of Gene and Cell Therapy (ASGCT) Virtual Annual Meeting
2020-04-27,Earnings Preview: uniQure (QURE) Q1 Earnings Expected to Decline
2020-04-24,Why Sanofi CEO's Comments Lit A Fire Under Gene Therapy Stocks
2020-04-21,Does uniQure (NASDAQ:QURE) Have A Healthy Balance Sheet?
2020-04-17,"uniQure Announces the Nomination of Leonard E. Post, Ph.D. to its Board of Directors"
2020-03-30,uniQure to Participate in Multiple Upcoming Investor Conferences in April
2020-03-28,Hedge Funds Have Never Been This Bullish On Uniqure NV (QURE)
2020-03-26,"Biotech delays U.S. gene therapy launch due to outbreak, FDA discord"
2020-03-26,uniQure Announces Achievement of Target Patient Dosing in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Hemophilia B
2020-03-18,Biotech pushes blood disorder cell therapy to clinic after $80M round
2020-03-03,uniQure to Participate in Multiple Upcoming Industry Conferences in March
2020-03-02,"UniQure (QURE) Reports Q4 Loss, Tops Revenue Estimates"
2020-03-02,uniQure Announces 2019 Financial Results and Highlights Recent Company Progress
2020-03-02,uniQure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters
2020-02-27,uniQure Presents Multiple New Preclinical Data on AMT-130 at the CHDIs 15th Annual Huntingtons Disease Therapeutics Conference
2020-02-26,Why Earnings Season Could Be Great for uniQure (QURE)
2020-02-21,"Before You Buy uniQure N.V. (NASDAQ:QURE), Consider Its Volatility"
2020-02-20,UniQure (QURE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2020-02-04,uniQure Announces Presentations at the Upcoming 13th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
2020-01-31,uniQure to Participate in Multiple Upcoming Industry Conferences in February
2020-01-10,Cambridge startup raises $110M for re-doseable gene therapies
2020-01-07,uniQure (NASDAQ:QURE) Shareholders Have Enjoyed A Magnificent 1077% Share Price Gain
2019-12-24,BioMarin Files BLA for Gene Therapy to Treat Hemophilia A
2019-12-19,One particular field of drug development could dominate M&A in 2020
2019-12-19,uniQure Announces Publication of Preclinical Data for AMT-130 in Huntingtons Disease Supporting Non-Selective HTT-Lowering Approach
2019-12-17,5 Biotech Stocks That Have More Than Doubled This Year
2019-12-17,Will uniQure Continue to Surge Higher?
2019-12-17,"Atlas, MPM, Partners funnel $49M into a new gene-silencing startup"
2019-12-16,5 Biotech Stocks Set for Continued Rally in 2020
2019-12-08,uniQure Announces One-Year Follow-Up Data from the Phase IIb Study of Etranacogene Dezaparvovec and Long-Term Follow-Up Data for AMT-060 in Patients with Hemophilia B
2019-12-06,"The Zacks Analyst Blog Highlights: uniQure, Sarepta Therapeutics, BioMarin Pharmaceutical and Sangamo Therapeutics"
2019-12-05,Astellas-Audentes Deal Likely to Ignite More Acquisitions
2019-12-05,4 Solid Gene Therapy Buyout Bets Post Audentes-Astellas Deal
2019-12-05,Gene Therapy the Next Best Thing: Here's Why (Revised)
2019-12-04,Gene Therapy the Next Best Thing: Here's Why
2019-12-03,The Gene Therapy Names Moving On The Audentes Buyout Deal
2019-12-02,uniQure to Participate in Multiple Upcoming Industry Conferences in December
2019-11-30,Hedge Funds Have Never Been This Bullish On Uniqure NV (QURE)
2019-11-22,Investors Hope for More From Takeda Than a Healthy Dividend
2019-11-07,"uniQure N.V. (QURE) Shares March Higher, Can It Continue?"
2019-11-06,uniQure Announces Clinical Data Presentations at the 61st American Society of Hematology (ASH) Annual Meeting
2019-11-05,uniQure Announces the Allowance of New Patent Providing Further Protection of the Padua and Padua-Related Variants of Factor IX in Gene Therapy
2019-11-01,uniQure to Participate in Multiple Upcoming Industry Conferences in November
